Kalion

About:

Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.

Twitter/X: kalioninc

Top Investors: National Science Foundation, LaunchPad Venture, Boston Harbor Angels, Cherrystone Angel Group, Beta Fund

Description:

Kalion is an early stage industrial biotech company that will transform the traditional chemical industry by providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional, green, fermentation technology. Glucaric acid and 3-HBL were identified as “Top Value Added Chemicals from Biomass” and multi-billion dollar markets for use of the two chemicals are limited by cost and availability (2004 DOE report).

Total Funding Amount:

$6.09M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Milton, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)kalioninc.com

Founders:

Kristala Prather, Neal Connors

Number of Employees:

1-10

Last Funding Date:

2020-06-18

IPO Status:

Private

Industries: